Literature DB >> 2404571

Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.

Y Nagata1, M Abe, K Kobayashi, K Yoshida, T Ishibashi, T Naoe, E Nakayama, H Shiku.   

Abstract

Point mutations of c-ras genes were analyzed in human gastrointestinal cancers. DNA obtained from the tissues was amplified by polymerase chain reaction and then analyzed by dot blot hybridization assay with oligonucleotide probes to detect mutations at codons 12, 13, and 61 of c-Ki-ras, c-Ha-ras, and c-N-ras. In two of 25 cases of stomach cancer point mutations at codon 13 of c-Ki-ras were found. In colorectal cancer, eight of 30 cases showed mutations: four cases of codon 12 and one case at codon 13 of c-Ki-ras and two cases at codon 61 and one case at codon 13 of c-N-ras. These results may indicate involvement of a wide variety of c-ras gene point mutations, in addition to those at codon 12 of c-Ki-ras, in oncogenesis of human gastrointestinal cancers. In all three mutations of c-Ki-ras at codon 13 which had been seldom found in human cancers, glycine to aspartic acid mutations due to identical G to A transition at the second nucleotide were observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404571

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

Authors:  Georgios Antonios Margonis; Yuhree Kim; Gaya Spolverato; Aslam Ejaz; Rohan Gupta; David Cosgrove; Robert Anders; Georgios Karagkounis; Michael A Choti; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2015-08       Impact factor: 14.766

2.  K-ras mutations in sporadic colorectal tumors in Israel: unusual high frequency of codon 13 mutations and evidence for nonhomogeneous representation of mutation subtypes.

Authors:  Dmitry Kislitsin; Aaron Lerner; Gad Rennert; Zeev Lev
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

3.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

4.  Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer.

Authors:  Meifang Zhang; Wenwei Hu; Kun Hu; Yong Lin; Zhaohui Feng; Jing-Ping Yun; Nan Gao; Lanjing Zhang
Journal:  Cancer Causes Control       Date:  2020-05-11       Impact factor: 2.506

5.  Absence of ras gene mutations in early gastric carcinomas.

Authors:  M E Craanen; P Blok; B Top; L Boerrigter; W Dekker; G J Offerhaus; G N Tytgat; S Rodenhuis
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

6.  Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours.

Authors:  M Yukawa; T Fujimori; S Maeda; M Tabuchi; K Nagasako
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

7.  Next-generation sequencing reveals the biological significance of the N(2),3-ethenoguanine lesion in vivo.

Authors:  Shiou-chi Chang; Bogdan I Fedeles; Jie Wu; James C Delaney; Deyu Li; Linlin Zhao; Plamen P Christov; Emily Yau; Vipender Singh; Marco Jost; Catherine L Drennan; Lawrence J Marnett; Carmelo J Rizzo; Stuart S Levine; F Peter Guengerich; John M Essigmann
Journal:  Nucleic Acids Res       Date:  2015-04-02       Impact factor: 16.971

8.  Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

Authors:  K Kubo; T Naoe; K R Utsumi; Y Ishiguro; K Ueda; H Shiku; K Yamada
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

9.  Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins.

Authors:  Susanna Cogoi; Manikandan Paramasivam; Barbara Spolaore; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2008-05-19       Impact factor: 16.971

10.  Infrequent ras mutation in human stomach cancers.

Authors:  M Koshiba; O Ogawa; T Habuchi; S Hamazaki; T Shimada; R Takahashi; T Sugiyama
Journal:  Jpn J Cancer Res       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.